美股市場個股詳情

EWTX Edgewise Therapeutics

添加自選

17.480
-0.850-4.64%

收盤價 05/13 16:00 (美東)

17.480
0.0000.00%

盤後 16:20 (美東)

16.33億總市值-11350市盈率TTM

Edgewise Therapeutics股票討論區

登錄發表評論

Jaguar8

04/16 04:07

$Edgewise Therapeutics(EWTX.US)$
NEWS
Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)
Positive two-year topline results from the ARCH trial show stabilization of NSAA scores with sevasemten treatment in adults with Becker Muscular Dystrophy.
Significant decreases in muscle damage biomarkers CK and TNNI2 were observed in participants treated with sevasemten.
Sevasemten was...

SlowndEasyTrades

02/02 00:44

$Edgewise Therapeutics(EWTX.US)$ 👀bought back again here looks in good shape all time

SlowndEasyTrades

02/01 09:08

$Edgewise Therapeutics(EWTX.US)$ back in my 👀 awaiting panic last dip as new stretegic move lol

SlowndEasyTrades

01/27 04:13

$Edgewise Therapeutics(EWTX.US)$ sold here missed eps estimates dont want to see position red 👍🏻

SlowndEasyTrades

01/20 02:00

$Edgewise Therapeutics(EWTX.US)$ big move here!👀

Moomoo AI

2023/12/30 20:35

The considerable share sell-off by Co-Founder and low insider ownership at Edgewise Therapeutics may indicate disalignment with shareholders. This could suggest a lack of confidence in its future performance.

Co-Founder Alan Russell Sold A Bunch Of Shares In Edgewise Therapeutics

Moomoo AI

2023/12/08 20:49

Edgewise Therapeutics' rising cash burn signals concern. Shareholders could experience costly dilution if the company sells shares to fund another year's growth. It's advised for shareholders to keep a close eye on the company's cash burn.